Detalhe da pesquisa
1.
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.
Mol Med
; 27(1): 15, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579185
2.
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma.
Front Pharmacol
; 12: 691769, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335258
3.
The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer.
Int J Biol Sci
; 15(7): 1523-1532, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337981
4.
In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.
Chem Biol Drug Des
; 89(4): 505-513, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664399
5.
Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells.
Sci Rep
; 7(1): 17987, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269744
6.
Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma.
Mol Med Rep
; 12(5): 6501-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26398439
7.
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug.
PLoS One
; 10(7): e0132072, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26147897